EXJADE (deferasirox dispersible tablets) Patient Assistance Program
Don’t let the high cost of brand iron chelation therapy disrupt your treatment. We help eligible patients access Exjade (deferasirox dispersible tablets) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Exjade (deferasirox) is FDA-approved for the treatment of chronic iron overload due to blood transfusions in adults and pediatric patients ≥2 years, and non-transfusion-dependent thalassemia syndromes in patients ≥10 years with iron overload. It is an oral iron chelator. Exjade is the original dispersible tablet formulation; Jadenu is the newer film-coated tablet formulation (more convenient).
- Without assistance, brand Exjade costs commonly run approximately $5,000–$8,500 per 30-day supply (varies by weight-based dose).
- Through AffordMyPrescriptions, qualifying patients can access Exjade for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- Generic deferasirox is now widely available in the U.S. at substantially lower cost. Both the original dispersible tablet (Exjade) and the newer film-coated tablet (Jadenu) are available as generics. Other iron chelators include deferoxamine (Desferal, generic — older, requires SC infusion 8–12 hours/day, 5–7 nights/week; very inexpensive but burdensome) and deferiprone (Ferriprox — three-times-daily oral; effective for cardiac iron overload).
What Is Exjade Prescription Assistance Program?
The Exjade Prescription Assistance Program is a manufacturer-sponsored initiative that provides Exjade at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for chronic iron overload patients who are uninsured or underinsured.
Navigating the program on your own means dealing with eligibility verification, hematology coordination, prior-authorization documentation, specialty pharmacy logistics, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment.
Pharmacy Price Comparison
- Without assistance, brand Exjade costs roughly $5,000–$8,500/month. Generic deferasirox is much cheaper. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (brand) | ~$8,200 | Save substantially |
| CVS Pharmacy (brand) | ~$8,500 | Save substantially |
| Walmart (brand) | ~$5,300 | Save substantially |
| Costco (brand) | ~$5,200 | Save substantially |
Generic deferasirox | ~$1,500 | Save substantially |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Exjade Prescription Program?
The Patient Assistance Program is free to apply for and provides Exjade at no medication cost if approved. Our $69.95/month service covers full advocacy. With generic deferasirox widely available at substantially lower cost, generic is usually the cheaper path for most patients.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Exjade:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $5,000–$8,500 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Exjade assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Exjade Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured Or Underinsured And Cannot Afford Your Medication
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Exjade:
Exjade (deferasirox) is an oral iron chelator used to remove excess iron from the body in patients with chronic iron overload — typically caused by long-term red blood cell transfusions (thalassemia major, sickle cell disease, MDS, other transfusion-dependent anemias). Untreated iron overload causes organ damage, particularly cardiac and hepatic.
How Exjade Works:
Because the body lacks a significant mechanism to excrete excess iron, chronic red blood cell transfusions lead to iron overload after 10 to 20 units are received. This excess iron deposits dangerously into vital tissues like the heart, liver, and endocrine glands, making iron chelation therapy essential to prevent organ damage. Deferasirox works as a tridentate iron chelator, meaning three of its molecules bind to one iron atom to form a stable, water-soluble complex that is excreted primarily through feces. This oral daily medication offers a much more convenient option than older alternatives that require lengthy, hours-long infusions.
Form and use:
Exjade dispersible tablets must be dissolved in water, orange juice, or apple juice and taken on an empty stomach at least 30 minutes before eating. In contrast, the newer Jadenu film-coated tablets can be swallowed whole and taken with a light meal, though both formulations are taken once daily. The typical starting dose is 20 mg/kg/day, which is later adjusted based on the patient’s serum ferritin levels and overall tolerability. Close monitoring of both renal and hepatic functions is strictly required for patients throughout the entire duration of the therapy.
Generic availability:
Generic deferasirox is widely available in the United States in both the dispersible and film-coated tablet formulations. Other iron chelator options include deferoxamine, an inexpensive but less convenient injectable requiring lengthy overnight infusions, and deferiprone, an oral option taken three times daily that is effective for cardiac iron overload. Depending on the patient’s unique clinical situation, some individuals with severe iron overload may require combination chelation using multiple therapies simultaneously. The choice between these medications relies heavily on specific patient factors, including the severity of cardiac iron overload and blood count monitoring needs.
Warnings:
Exjade carries serious boxed warnings for potentially fatal renal failure, acute liver failure, and severe gastrointestinal hemorrhage, particularly in elderly or advanced cancer patients. Weekly serum creatinine monitoring is required during dose titration, followed by monthly checks alongside regular liver function tests to ensure patient safety. Additional warnings highlight the risks of severe skin reactions like Stevens-Johnson syndrome, bone marrow suppression, and both auditory and ocular disturbances. Finally, clinicians must monitor serum ferritin levels closely to prevent the risks associated with overchelation when iron stores drop too low.
FAQ (Frequently Asked Questions)
How Much Does Exjade Cost Without Insurance?
Brand Exjade costs approximately $5,000–$8,500 per 30-day supply (varies by weight-based dose). Generic deferasirox is dramatically cheaper. Through AffordMyPrescriptions, qualifying patients receive Exjade at no medication cost — our $69.95 monthly fee covers full advocacy and program management. Most patients find generic deferasirox is the cheaper path.
Is Generic Deferasirox The Same As Brand Exjade?
Yes. The FDA approves generic deferasirox as bioequivalent to brand. Both the dispersible tablet (Exjade) and film-coated tablet (Jadenu) formulations have generic versions. Most hematologists and insurance plans prefer generic.
What's The Difference Between Exjade Dispersible And Jadenu?
Same active drug, different formulation. Exjade dispersible tablets must be dispersed in water/juice and swallowed as a slurry — taken on empty stomach 30 minutes before food. Jadenu film-coated tablets are swallowed whole with light food allowed. Most patients prefer Jadenu for convenience. Both have similar efficacy. Both available as generic. Discuss with your hematologist which form is best for you.
Why Do I Need Iron Chelation?
Chronic blood transfusions deliver iron that can’t be excreted by the body — accumulating in organs and causing serious damage. Untreated transfusional iron overload causes cardiomyopathy and heart failure (a leading cause of death in transfusion-dependent thalassemia), liver fibrosis/cirrhosis, hypogonadism, diabetes, and other endocrine dysfunction. Iron chelation therapy starting after sufficient transfusion burden (typically 10–20 units RBC or ferritin >1000) is essential to prevent these complications.
What Monitoring Do I Need?
Frequent monitoring: serum creatinine (weekly during titration, monthly stable), LFTs (monthly), CBC (monthly), serum ferritin (every 1–3 months, target ferritin <1000 ng/mL once stable), iron stores (MRI T2* for cardiac and liver iron annually), eye exam and audiology (yearly). Dose adjustments based on response and toxicity.
Are There Drug Interactions I Should Know About?
Yes. Aluminum-containing antacids interfere with deferasirox — separate by at least 2 hours. Bile acid sequestrants (cholestyramine, colesevelam, colestipol) reduce deferasirox absorption — avoid concurrent use. Strong UGT inducers (rifampin, phenytoin, phenobarbital, ritonavir) and CYP3A4 substrates can have significant interactions. Tell every prescriber and pharmacist about deferasirox.
What If My Application Is Denied?
If denied, we explore alternatives — switching to generic deferasirox (much cheaper), generic deferoxamine if SC infusions are acceptable (very cheap), Ferriprox if appropriate (especially for cardiac iron), the manufacturer’s copay program for commercially insured patients, or independent foundations such as the Cooley’s Anemia Foundation (thalassemia), Sickle Cell Disease Association, PAN Foundation, or HealthWell Foundation. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Exjade, our team may be able to help you access assistance programs — or guide you to generic deferasirox. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.